Article Details
Retrieved on: 2023-11-02 15:44:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer and BioNtech have announced positive topline data from a vaccine phase 1/2 study (NCT0T05596734), demonstrating immune response to influenza A, ...
Article found on: www.ajmc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here